Marques Tiago

Marques Tiago, Chief Executive Officer, Director, accounts for 2 disclosed filings worth $377.7K, all concentrated in Pasithea Therapeutics Corp. (KTTA), active 2025. The record is heavily weighted toward buying, with $25.0K in purchases against $0 in sales. The largest single open-market purchase on record is $25.0K in Pasithea Therapeutics Corp.. Data is sourced from official SEC Form 3, 4, and 5 filings.